17 people died as a result of an explosion at a pharmaceutical factory
Tengrinews.kz – A powerful explosion occurred at a pharmaceutical plant in the Indian state of Andhra Pradesh, resulting in at least 17 deaths
Biotech stocks fall as Clinton slams high drug prices
Biotech stocks took a hit after Democratic presidential frontrunner Hillary Clinton pledged to take action against runaway price increases on specialty drugs.
French drugmaker delivers first semi-synthetic malaria drugs
French pharmaceutical giant Sanofi announced the delivery of the first anti-malaria drugs to millions of patients in Africa.
FedEx indicted for shipping illegal online pharmacy meds
The US Justice Department announced that package-delivery giant FedEx has been indicted for allegedly facilitating the distribution of controlled substances and prescription drugs sold by illegal online pharmacies.
Japan prosecutors arrest ex-Novartis employee over data
Prosecutors on Wednesday arrested a former employee of the Japanese unit of Swiss pharmaceutical giant Novartis for allegedly manipulating research data to exaggerate the benefits of a popular blood-pressure drug.
Germany's Bayer says new products drive Q1 growth
German chemicals and pharmaceuticals giant Bayer, maker of Aspirin, said on Monday it turned in a better first quarter performance than expected thanks to healthy growth driven by new products.
GSK, Novartis unveil major healthcare revamp
British pharmaceutical giant GlaxoSmithKline and Swiss peer Novartis announced a major shake-up of their healthcare divisions on Tuesday in deals worth billions of dollars.
Indian drug maker Sun to buy troubled peer Ranbaxy for $4.0 bln
Top Indian drug giant Sun Pharmaceutical Industries said Monday it had agreed to buy its troubled peer Ranbaxy for $4.0 billion in stock, ending its ill-fated six-year control by Japan's Daiichi Sankyo.
Novartis replaces top Japan executives over drug trial scandal
Swiss pharmaceutical giant Novartis said Thursday it was replacing the top executives at its Japanese unit over allegations the division hid serious potential side effects of leukaemia treatments from regulators.
New Japan research scandal brewing over Alzheimer's study
Japan's health ministry said Friday it was probing claims falsified data was used in an Alzheimer's disease study involving major pharmaceutical firms, a day after filing an unrelated criminal complaint against Swiss drugs giant Novartis.
Japan's top drugmaker appoints first foreign boss
Japan's top drugmaker said Saturday it had picked a GlaxoSmithKline executive as its next president in a rare example of overseas head-hunting by a major Japanese firm.
GSK to seek green light for malaria vaccine
British drug maker GlaxoSmithKline (GSK) said on Tuesday it hoped to get the green light for a prototype vaccine against malaria after trials showed it offered children a partial shield against the disease.
China details charges against foreign fraud investigators
Chinese state television put two foreign fraud investigators on display Tuesday as police announced they had been charged with illegally obtaining personal information.
US fines Wyeth $490.9 mn for illegal drug marketing
Wyeth Pharmaceuticals has pleaded guilty to misbranding a drug that prevents the rejection of organ transplants and agreed to pay $490.9 million.
Pfizer to invest in clinical tests in Kazakhstan
The pharmaceutical giant will invest in development of clinical test centers in Kazakhstan.
Poorest WTO members win new patent-rule waiver
The globe's poorest nations have won an eight-year extension of a waiver on intellectual property rules, but still need to hold talks on the vexed issue of pharmaceutical patents.
UPS to pay $40 million for illegal pharma shipments
UPS Friday agreed to forfeit $40 million and implement a compliance program after a Department of Justice probe found the company delivered drugs on behalf of illegal online pharmacies.
Kazakhstan’s pharmaceutical market to grow 15 percent in 2013
The volume of Kazakhstan pharmaceutical market makes $1.2 billion; it has been maintaining an upward trend for several years already.
US drug firm Mylan to buy Indian firm for $1.6 bn
US generic drugs specialist Mylan said Thursday it would buy a unit of India's pharma firm Strides Arcolab for $1.6 billion, boosting its presence in the high-growth injectable drugs market.
Pfizer unit Zoetis makes strong market debut
Zoetis, pharmaceutical giant Pfizer's animal-health division, made a dramatic debut on Wall Street Friday as the biggest initial public offering since Facebook.